BioLineRx annual gross profit
2021
2022
2023
2024
2025
BioLineRx Gross Profit Growth & History (BLRX)
BioLineRx's gross profit was $950,000 for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $950,000 | −$18.7M | −95.17% |
| 2024 | 2024-12-31 | $19.7M | $18.6M | +1675.90% |
| 2023 | 2023-12-31 | $1.1M | $1.1M | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | — | — |
BioLineRx quarterly gross profit
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $235,000 | $3,000 | +1.29% |
| Q1 2026 | 2026-03-31 | $382,000 | $161,000 | +72.85% |
| Q4 2025 | 2025-12-31 | $154,000 | — | — |
| Q3 2025 | 2025-09-30 | $343,000 | — | — |
| Q2 2025 | 2025-06-30 | $232,000 | −$4.3M | −94.84% |
| Q1 2025 | 2025-03-31 | $221,000 | — | — |
| Q2 2024 | 2024-06-30 | $4.5M | $4.5M | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
BioLineRx gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, BioLineRx's gross profit increased from $0 to $950,000, a change of $950,000. The latest reported quarter, Q2 2026, shows $235,000.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx source filings ↗